Therapeutic Effect of Nicotinamide Mononucleotide for Hypoxic-Ischemic Brain Injury in Neonatal Mice

被引:5
|
作者
Kawamura, Takuya [1 ,2 ]
Mallah, Gagandeep Singh [1 ]
Ardalan, Maryam [1 ]
Chumak, Tetyana [1 ]
Svedin, Pernilla [1 ]
Jonsson, Lina [1 ]
Shiadeh, Seyedeh Marziyeh Jabbari [1 ]
Goretta, Fanny [1 ]
Ikeda, Tomoaki [2 ]
Hagberg, Henrik [3 ]
Sandberg, Mats [4 ]
Mallard, Carina [1 ,5 ]
机构
[1] Univ Gothenburg, Inst Neurosci & Physiol, Sahlgrenska Acad, Ctr Perinatal Med & Hlth, Gothenburg, Sweden
[2] Mie Univ, Dept Obstet & Gynecol, Tsu, Japan
[3] Inst Clin Sci, Ctr Perinatal Med & Hlth, Gothenburg, Sweden
[4] Univ Gothenburg, Inst Biomed, Sahlgrenska Acad, Gothenburg, Sweden
[5] Univ Gothenburg, Inst Neurosci & Physiol, Sahlgrenska Acad, Box 432, S-40530 Gothenburg, Sweden
来源
ASN NEURO | 2023年 / 15卷
关键词
sirtuins; alarmins; infant; therapy; hypoxic-ischemic encephalopathy; nicotinamide adenine dinucleotide; MOBILITY GROUP BOX-1; NAD(+) METABOLISM; PROTEIN SIR2; HMGB1; DAMAGE; LOCALIZATION; HYPOTHERMIA; DISRUPTION; EXPRESSION; MEDIATOR;
D O I
10.1177/17590914231198983
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
A clinical challenge remains in the treatment of hypoxic-ischemic brain injury in newborns. Nicotinamide adenine dinucleotide (NAD+) has beneficial effects in animal models of adult stroke. Here, we aimed to understand the short- and long-term neuroprotective effects of NAD+-promoting substance nicotinamide mononucleotide (NMN) in a well-established brain injury model in neonatal mice. Postnatal day (PND) 9 male and female mice were subjected to cerebral hypoxia-ischemia and treated with saline or NMN (50 mg/kg) immediately after hypoxia-ischemia. At different time points after hypoxia-ischemia, hippocampal NAD+, caspase-3 activity, protein expression of SIRT1, SIRT6, release of high mobility group box-1 (HMGB1), long-term neuropathological outcome, short-term developmental behavior, and long-term motor and memory function were evaluated. Neonatal hypoxia-ischemia reduced NAD+ and SIRT6 levels, but not SIRT1, in the injured hippocampus, while HMGB1 release was significantly increased. NMN treatment normalized hippocampal NAD+ and SIRT6 levels, while caspase-3 activity and HMGB1 release were significantly reduced. NMN alleviated tissue loss in the long-term and improved early developmental behavior, as well as motor and memory function. This study shows that NMN treatment provides neuroprotection in a clinically relevant neonatal animal model of hypoxia-ischemia in mice suggesting as a possible novel treatment for neonatal brain injury.Summary StatementNeonatal hypoxia-ischemia reduces nicotinamide adenine dinucleotide (NAD+) and SIRT6 levels in the injured hippocampus.Hippocampal high mobility group box-1 (HMGB1) release is significantly increased after neonatal hypoxia-ischemia.Nicotinamide mononucleotide (NMN) treatment normalizes hippocampal NAD+ and SIRT6 levels, with significant decrease in caspase-3 activity and HMGB1 release.NMN improves early developmental behavior, as well as motor and memory function. Graphical AbstractThis is a visual representation of the abstract.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] Therapeutic Hypothermia as a Neuroprotective Strategy in Neonatal Hypoxic-Ischemic Brain Injury and Traumatic Brain Injury
    Ma, H.
    Sinha, B.
    Pandya, R. S.
    Lin, N.
    Popp, A. J.
    Li, J.
    Yao, J.
    Wang, X.
    CURRENT MOLECULAR MEDICINE, 2012, 12 (10) : 1282 - 1296
  • [2] The Neuroprotective Effects of Quercetin on Hypoxic-ischemic Brain Injury in Neonatal Mice
    Jing, Bai-Qian
    Zhao, Liang
    Jing, Wei
    Zhang, Yu-Xia
    LATIN AMERICAN JOURNAL OF PHARMACY, 2019, 38 (04): : 651 - 658
  • [3] Ceftriaxone attenuates hypoxic-ischemic brain injury in neonatal rats
    Lai, Pei Chun
    Huang, Yen Ta
    Wu, Chia Chen
    Lai, Ching-Jung
    Wang, Pen Jung
    Chiu, Ted H.
    JOURNAL OF BIOMEDICAL SCIENCE, 2011, 18
  • [4] Pyruvate Dehydrogenase Complex in Neonatal Hypoxic-Ischemic Brain Injury
    Zhou, Tao
    Zhong, Yuangao
    Zhang, Yong
    Zhou, Yue
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2023, 7 (01) : 42 - 47
  • [5] MicroRNA therapeutic targets in neonatal hypoxic-ischemic brain injury: a narrative review
    Peeples, Eric S.
    PEDIATRIC RESEARCH, 2023, 93 (04) : 780 - 788
  • [6] Cannabidiol for the Treatment of Neonatal Hypoxic-Ischemic Brain Injury
    Martinez-Orgado, Jose
    Villa, Maria
    del Pozo, Aaron
    FRONTIERS IN PHARMACOLOGY, 2021, 11
  • [7] Neuroprotective Effect of Lacosamide on Hypoxic-Ischemic Brain Injury in Neonatal Rats
    Kim, Gun-Ha
    Byeon, Jung Hye
    Eun, Baik-Lin
    JOURNAL OF CLINICAL NEUROLOGY, 2017, 13 (02): : 138 - 143
  • [8] Effect of combined therapy with ephedrine and hyperbaric oxygen on neonatal hypoxic-ischemic brain injury
    Chen, Siyuan
    Xiao, Nong
    Zhang, Xiaoping
    NEUROSCIENCE LETTERS, 2009, 465 (02) : 171 - 176
  • [9] Hypothermia for hypoxic-ischemic brain injury
    Parish, Anjali
    Bhatia, Jatinder
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2009, 22 (09) : 719 - 721
  • [10] Therapeutic hypothermia for neonatal hypoxic-ischemic encephalopathy
    Gulczynska, Ewa
    Gadzinowski, Janusz
    GINEKOLOGIA POLSKA, 2012, 83 (03) : 214 - 218